










 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Stonepine Capital, L.P.: Private Company Information - Bloomberg









































  





















































































July 28, 2017 1:06 PM ET
Capital Markets

Company Overview of Stonepine Capital, L.P.



Snapshot People




Company Overview



220 Halleck StreetSuite 220San Francisco, CA 94129United States










Key Executives for Stonepine Capital, L.P.


Stonepine Capital, L.P. does not have any Key Executives recorded. 





Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Stonepine Capital, L.P., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Stonepine Capital Management LLC: Private Company Information - Bloomberg









































  





















































































July 28, 2017 1:06 PM ET
Capital Markets

Company Overview of Stonepine Capital Management LLC



Snapshot People




Company Overview



220 Halleck StreetSuite 220San Francisco, CA 94129United States



www.stonepinecap.com







Key Executives for Stonepine Capital Management LLC




Mr. Jon M. Plexico


      	General Partner and Founder
      


Age: 49
        







Mr. Timothy P. Lynch


      	General Partner and Co-Managing Partner
      


Age: 47
        




Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target





Merger/Acquisition

			      September 20, 2016
			    
Tobira Therapeutics, Inc.





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Stonepine Capital Management LLC, please visit www.stonepinecap.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























 Stonepine Capital, L.p. Insider Stock Buys/Sells - InsiderRank.com
























Stonepine Capital, L.p. Follow


Latest transaction date: 2016-09-15    Buy transactions: 2    Sell transactions: 0 

* All Performance calculations are based on adjusted end of day stock price.



1 Mo3 Mo6 Mo1 Yr2 Yr3 Yr


Average Purchase Return828.57%25.05%828.57%700%00


Purchase Success Rate1/12/21/11/10/00/0


Average Sale Return000000


Sale Success Rate0/00/00/00/00/00/0







Stonepine Capital, L.p.: 10% Owner in QLTI


Stonepine Capital, L.p.: 10% Owner in QLTI


QLTI Price ($): 

 Mkt Cap ($Mil)

P/E Ratio


* All Performance calculations are based on adjusted end of day stock price.



1 Mo3 Mo6 Mo1 Yr2 Yr3 Yr


Average Purchase ReturnN/AN/AN/A---


Purchase Success Rate0/10/10/1---


Average Sale Return------------


Sale Success Rate------------








All Transactions by Stonepine Capital, L.p. in QLTI


Performance Analysis








Insider
Title
Transaction Date
Type
Shares
Price(Filing)
Price(EOD Adjusted)
Value(Filing)
1M PriceChange(%)
3M PriceChange(%)
6M PriceChange(%)
1Y PriceChange(%)
Filing


STONEPINE CAPITAL, L.P.10% Owner2016-09-15Buy133,496$1.55N/A$206,919N/AN/AN/AN/A












Stonepine Capital, L.p.: 10% Owner in VIVMF


Stonepine Capital, L.p.: 10% Owner in VIVMF


VIVMF Price ($): 

 Mkt Cap ($Mil)

P/E Ratio


* All Performance calculations are based on adjusted end of day stock price.



1 Mo3 Mo6 Mo1 Yr2 Yr3 Yr


Average Purchase ReturnN/AN/AN/AN/A--


Purchase Success Rate0/10/10/10/1--


Average Sale Return------------


Sale Success Rate------------








All Transactions by Stonepine Capital, L.p. in VIVMF


Performance Analysis








Insider
Title
Transaction Date
Type
Shares
Price(Filing)
Price(EOD Adjusted)
Value(Filing)
1M PriceChange(%)
3M PriceChange(%)
6M PriceChange(%)
1Y PriceChange(%)
Filing


STONEPINE CAPITAL, L.P.10% Owner2015-11-24Buy2,857,142$0.7N/A$2,000,000N/AN/AN/AN/A


















2017 InsiderRank.com







×
"insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." - Peter Lynch






Username



Email Confirmation required



Password



Confirm Password



Create new account




Already registered?













Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft














Stonepine Capital Management





































            Stonepine Capital is a life-science focused investment management company        


Team
Jon M. Plexico founded Stonepine Capital Management LLC in 2006, where he is currently a Managing Member. Previously, Mr. Plexico was Managing Director at Merriman Curhan Ford & Co., where he led healthcare corporate finance focusing on corporate financings and mergers and acquisitions. Prior to that, Mr. Plexico was an early employee at Chemdex Corporation, an e-commerce life-science company that grew to over 500 employees and completed an IPO during his tenure. He began his career at Quidel Corporation, where he became National Sales Manager for the Autoimmune Division. He has served on the Boards of Directors of Zila, Inc., Immunetech, and currently serves on the Board of Viveve Medical, Inc. Mr. Plexico is a graduate of Colgate University.
Timothy P. Lynch joined Stonepine Capital Management LLC as a Managing Member in 2008. Previously he served as Chief Financial Officer at Tercica, Inc. and InterMune, Inc. Mr. Lynch also worked in corporate development for Elan Corporation plc and began his career with Goldman, Sachs & Co. He has served on the Boards of Directors of Aradigm Corporation, Allos Therapeutics, Bioform Medical, Insite Vision, and Nabi Biopharmaceuticals. He has also served as a member of the Cowen Healthcare Royalty Fund’s strategic advisory board. Mr. Lynch is a graduate of Colgate University and Harvard Business School.
Jeffrey P. Nunnenkamp joined Stonepine Capital Management LLC as Chief Operating Officer and Chief Compliance Officer in 2017. Prior to joining Stonepine, Mr. Nunnenkamp was Vice President of Alternative Funds Finance at PIMCO with responsibility for hedge funds finance and operations. With over 15 years relevant experience, his previous positions include Manager of fixed income portfolio accounting at Wells Capital Management, Second Vice President at Northern Trust where he managed the hedge fund administration group, and Supervisor of global portfolio administration at Western Asset Management. He holds an MBA in finance from Loyola Marymount University, a BBA in Marketing Management from the University of Portland, and is a Certified Public Accountant.
Matthew B. Carroll joined Stonepine Capital Management LLC in 2012 and is Director of Research. He has nearly a decade of experience specializing in accounting, finance and tax matters. Prior to joining Stonepine, Mr. Carroll ran a CPA firm, Tyler & Carroll, LLC which he co-founded. Previously, he worked in the furniture industry and at Dell, Inc. in Austin, Texas. Mr Carroll has taught bookkeeping courses and served as treasurer and board member for a local not-for-profit organization. Mr. Carroll holds a bachelor’s degree in business with an emphasis in accounting from Linfield College and is a Certified Public Accountant (inactive).
Nathan M. LiaBraaten joined Stonepine Capital Management LLC as Research Associate in 2015. Prior to joining Stonepine, Mr. LiaBraaten was a financial advisor with Bank of America Merrill Lynch focusing on the needs of small- to mid-sized businesses. Previously, he held a business development role with Vencore Capital, a venture debt firm, where he was responsible for developing, underwriting, and managing a portfolio of business loans to early-stage companies. He attended the University of Oregon where earned an MBA in finance and bachelor’s degrees in business administration and psychology.





Sidebar
Contact Stonepine Capital Management, LLC
919 NW Bond Street
Suite 204
Bend, OR 97703
info@stonepinecap.com










Search Anything


Search for:



 




Close








Track insider buy and sell






Home
Latest Filings 
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts





 STONEPINE CAPITAL L P 
        
- As of  07/28/17, 01:06:26 PM:   45 Insider Transactions.
Email this page to a friend.

 










Buy/Sell*
1 Yr Return**
Filed Date
Subject
Symbol

Pct Owned
Details


S
 
2016-11-21 17:20:05
VIVEVE MEDICAL
VIVE

24.4%
view


B
 
2016-11-17 14:48:38
ALIMERA SCIENCES INC
ALIM

5.4%
view


B
 
2016-11-02 11:53:17
TRINITY BIOTECH PLC
n/a

6.2%
view


S
 
2016-09-23 16:11:54
Tobira Therapeutics
TBRA

4.3%
view


B
 
2016-09-16 13:46:13
QLT INC
QLTI

10.9%
view


B
 
2016-09-16 13:16:15
Cardiome Pharma Corp
CRME

5.6%
view


B
 
2016-07-21 16:20:48
Recro Pharma
REPH

5.5%
view


B
 
2016-03-24 16:07:04
PERNIX THERAPEUTICS HOLDINGS
PTX

6.1%
view


B
 
2016-03-24 15:54:39
VIVEVE MEDICAL
VIVMF

30.7%
view


B
 
2016-02-12 13:22:05
Vericel Corp
ASTM

9.99%
view


S
 
2016-02-12 13:21:05
Tobira Therapeutics
TBRA

4.4%
view


B
 
2016-02-12 13:19:56
PHOTOMEDEX INC
PHMD

12.0%
view


S
 
2016-02-12 13:18:43
PERNIX THERAPEUTICS HOLDINGS
PTX

4.1%
view


B
 
2016-02-12 13:17:49
PAIN THERAPEUTICS INC
PTIE

7.8%
view


B
 
2016-02-12 13:16:53
ENZON PHARMACEUTICALS INC
ENZN

12.0%
view


B
 
2016-02-12 13:15:50
AMARIN CORP PLC
AMRN

12.0%
view


B
 
2016-02-11 19:33:56
Aegerion Pharmaceuticals
AEGR

12.0%
view


B
 
2015-08-31 12:55:26
PERNIX THERAPEUTICS HOLDINGS
PTX

5.4%
view


B
 
2015-05-29 16:31:41
Aegerion Pharmaceuticals
AEGR

5.2%
view


B
 
2015-05-21 14:28:16
VIVEVE MEDICAL
VIVMF

30.6%
view


B
 
2015-03-09 15:42:18
PHOTOMEDEX INC
PHMD

5.9%
view


B
 
2015-02-09 13:35:27
AMARIN CORP PLC
AMRN

6.5%
view


B
 
2015-02-05 18:03:14
AMARIN CORP PLC
n/a

6.5%
view


B
 
2015-02-05 17:50:58
PAIN THERAPEUTICS INC
PTIE

6.8%
view


B
 
2015-02-05 17:49:11
Regado Biosciences Inc
RGDO

9.99%
view


S
 
2015-02-05 17:46:15
ENZON PHARMACEUTICALS INC
ENZN

7.7%
view


B
 
2015-02-05 17:44:47
Vericel Corp
ASTM

7.5%
view


S
 
2015-02-05 17:43:02
SCICLONE PHARMACEUTICALS INC
SCLN

0.7%
view


B
 
2014-11-26 12:44:37
Regado Biosciences Inc
RGDO

5.8%
view


B
 
2014-11-19 14:57:52
AMARIN CORP PLC
AMRN

5.2%
view


B
 
2014-11-10 15:12:24
PAIN THERAPEUTICS INC
PTIE

6.1%
view


B
 
2014-09-22 15:41:31
AASTROM BIOSCIENCES INC
ASTM

7.1%
view


B
 
2014-06-30 13:55:36
BIOSPECIFICS TECHNOLOGIES CORP
BSTC

14.0%
view


B
101.57%
2014-04-04 14:51:06
SCICLONE PHARMACEUTICALS INC
SCLN

5.3%
view


B
7.22%
2014-03-13 06:10:59
ENZON PHARMACEUTICALS INC
ENZN

9.5%
view


B
50.33%
2014-03-07 12:22:59
BIOSPECIFICS TECHNOLOGIES CORP
BSTC

6.39%
view


B
75.64%
2014-01-10 11:37:10
BIOSPECIFICS TECHNOLOGIES CORP
BSTC

5.6%
view


B
75.10%
2013-09-17 14:24:59
BIOSPECIFICS TECHNOLOGIES CORP
BSTC

5.1%
view


S
 
2013-08-07 08:27:33
Nile Therapeutics
NLTX

4.7%
view


S
 
2013-02-14 13:37:39
Nile Therapeutics
NLTX

9.15%
view


S
 
2012-05-04 17:24:59
Sucampo Pharmaceuticals
SCMP

4.96%
view


S
 
2012-04-13 16:47:00
Sucampo Pharmaceuticals
SCMP

6.3%
view


B
-74.07%
2012-02-15 17:00:00
Nile Therapeutics
NLTX

9.99%
view


B
-16.77%
2012-02-07 12:22:22
Sucampo Pharmaceuticals
SCMP

7.4%
view


B
-87.18%
2011-06-30 16:40:06
Nile Therapeutics
NLTX

9.99%
view



* Institutions do not report transaction buy/sell types directly.  To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.

** Since most institutions are long investors, only returns for long transactions are shown here.


